CC-99282 ± rituximab for R/R NHL: Phase I/II trial interim analysis
Jean-Marie Michot • 16 Jun 2023
Phase Ib trial of R-CHOP plus iberdomide or CC-99282 in aggressive B-cell lymphoma
Jason Westin • 11 Dec 2022
Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.